INDRAPRASTHA Buy Hold or Sell Recommendation

532150 -- India Stock  

INR 51.60  2.30  4.27%

Assuming the 30 trading days horizon, and your above-average risk tolerance our recommendation regarding INDRAPRASTHA MEDICAL CORP is 'Not Rated'. Macroaxis provides INDRAPRASTHA MEDICAL buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 532150 positions. The advice algorithm takes into account all of INDRAPRASTHA MEDICAL available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from 532150 buy-and-hold perspective. Please continue to Trending Equities.

Search Advice


Time Horizon

Risk Tolerance

Execute Advice
Not Rated
For the selected time horizon INDRAPRASTHA MEDICAL CORP has a risk adjusted performance of 0.4329, jensen alpha of 4.13, total risk alpha of 2.38 and treynor ratio of (23.93)
Our buy or sell recommendations tool can be used to complement INDRAPRASTHA MEDICAL CORP buy, hold, or sell suggestions provided by experts. It analyzes the entity's potential to grow against your specific risk preferences and investment horizon. Please check out INDRAPRASTHA MEDICAL price to earning, gross profit, as well as the relationship between the Gross Profit and market capitalization to decide if your INDRAPRASTHA MEDICAL buy or sell deciscion is justified.

INDRAPRASTHA MEDICAL Trading Alerts and Improvement Suggestions

INDRAPRASTHA MEDICAL is not yet fully synchronised with the market data
INDRAPRASTHA MEDICAL appears to be very risky and stock price may revert if volatility continues

INDRAPRASTHA MEDICAL Returns Distribution Density

The chart of the probability distribution of INDRAPRASTHA MEDICAL stock daily returns describes the distribution of returns around its average expected value. We use INDRAPRASTHA MEDICAL CORP' stock's Value At Risk and its Upside Potential as a relative measure of the distribution. The distribution of INDRAPRASTHA MEDICAL returns is essential to provide solid investment advice for INDRAPRASTHA MEDICAL stock.
Mean Return4.11Value At Risk-13.32
Potential Upside45.43Standard Deviation17.61
 Return Density 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of INDRAPRASTHA MEDICAL historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.


When is the right time to buy or sell INDRAPRASTHA MEDICAL CORP? Buying stocks such as INDRAPRASTHA MEDICAL isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily bases. Although INDRAPRASTHA MEDICAL investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply. Please read more on our stock advisor page.

Did You Try This Idea?

Run Baby Boomer Prospects Thematic Idea Now

Baby Boomer Prospects
Baby Boomer Prospects Theme
Equities with large market capitalization that account for significant contribution to overall economic growth especially within dividend-paying instruments and stocks from healthcare and financial sectors. Baby Boomer Prospects theme has 95 constituents.
View All  Next Launch Baby Boomer Prospects
Please continue to Trending Equities. Please also try Money Managers module to screen money managers from public funds and etfs managed around the world.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page